We investigated the association between the expression of ANRIL and clinicopathological features; our meta-analysis showed that overexpression of ANRIL is strongly associated with LNM (OR = 4.77, 95% CI: 2.30–9.91, P < 0.001) and clinical stage (OR = 3.44, 95% CI: 1.68–7.08, P < 0.001), whereas there was no significant association between high ANRIL expression and histological grade (OR = 1.42, 95% CI: 0.32–6.27, P = 0.646) or tumor size (OR = 1.77, 95% CI: 0.63–4.93, P = 0.278). Here, CDKN2B-AS1 is linked to neoplasm.